Pharmacological properties of GR38032F, a novel antagonist at 5‐HT3 receptors
Authors:
Open Access
- 1 June 1988
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 94 (2) , 397-412
Abstract
This paper describes the pharmacology of the novel 5‐hydroxytryptamine3 (5‐HT3) receptor antagonist GR38032F. On the isolated vagus nerve and superior cervical ganglion of the rat, R,S‐GR38032F behaved as a reversible competitive antagonist of 5‐HT‐induced depolarization with pKB values of 8.61 ± 0.08 (n = 19) and 8.13 ± 0.07 (n = 16), respectively. The resolved R‐ and S‐isomers of GR38032F were approximately equipotent as 5‐HT antagonists on the rat vagus nerve: the pKB values were 8.95 ± 0.05 (n = 16) and 8.63 ± 0.08 (n = 17), respectively. R,S‐GR38032F was also an effective antagonist of 5‐HT on the rabbit isolated vagus nerve: in this case the pKB value was 9.40 ±0.14 (n = 4). On the rabbit isolated heart, low concentrations of R,S‐GR38032F (3 × −1011 −1 × 10‐9 m) antagonized the positive chronotropic effect of 5‐HT and 2‐methyl‐5‐hydroxytryptamine (2‐methyl‐5‐HT). However, the effects of the compound did not appear consistent with simple reversible competition. On the longitudinal smooth muscle of the guinea‐pig ileum, R,S‐GR38032F caused concentration‐dependent parallel rightward displacement of the 2‐methyl‐5‐HT concentration‐contraction response curve; in contrast, a portion of the response to 5‐HT appeared resistant to R,S‐GR38032F. pKB values estimated from the effects of the compound against 2‐methyl‐5‐HT or the inhibitable portion of the response to 5‐HT were 7.31 ± 0.06 (n = 8) and 7.33 ± 0.13 (n = 8), respectively. Against 2‐methyl‐5‐HT, R‐GR38032F seemed more potent (pKB 7.20 ± 0.10; n = 6) than S‐GR38032F (pKB 6.30 ± 0.05; n = 6). R,S‐GR38032F is highly selective for 5‐HT3 receptors, and at concentrations of 3 × 10−6‐3 × 10−5m, had negligible agonist or antagonist activity on other 5‐HT or non‐5‐HT receptor‐containing tissues on which it was tested. The potency and duration of action of R,S‐GR38032F in blocking 5‐HT3 receptors in vivo were assessed by measuring its ability to antagonize the bradycardic response to 5‐HT or 2‐methyl‐5‐HT administered intravenously (i.v.) to anaesthetized animals. For i.v. administration to the rat, the ED50 for R,S‐GR38032F against 2‐methyl‐5‐HT (100 μg kg−1) was 0.4 (95% confidence limits 0.18–0.87) μg kg−1 (n = 10); the corresponding value for oral administration to this species was 7.0 (3.0–22.0) μg kg−1 (n = 8–10 per dose level). R,S‐GR38032F was similarly effective in the anaesthetized cat. The present results are discussed with reference to the postulated existence of subtypes of the 5‐HT3 receptor.Keywords
This publication has 29 references indexed in Scilit:
- Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brainEuropean Journal of Pharmacology, 1987
- Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamineNeuropharmacology, 1986
- The depolarizing action of 5‐hydroxytryptamine on rabbit vagal afferent and sympathetic neurones in vitro and its selective blockade by ICS 205–930British Journal of Pharmacology, 1986
- Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugsNature, 1985
- 5-hydroxytryptamine-induced relaxation of isolated mammalian smooth muscleEuropean Journal of Pharmacology, 1983
- Organ selectivity of drugs Alternatives to receptor selectivityTrends in Pharmacological Sciences, 1982
- Prenalterol is an agonist at β2- as well as at β1-adrenoceptorsEuropean Journal of Pharmacology, 1982
- Pharmacological interactions between ranitidine, cimetidine, metiamide and tiotidine at histamine H2-receptor sites in guinea-pig atriaInflammation Research, 1982
- EVIDENCE FOR TWO TYPES OF EXCITATORY RECEPTOR FOR 5‐HYDROXYTRYPTAMINE IN DOG ISOLATED VASCULATUREBritish Journal of Pharmacology, 1980
- Blockade of neuronal tryptamine receptors by metoclopramideEuropean Journal of Pharmacology, 1978